Detalhe da pesquisa
1.
Safety, pharmacokinetics and pharmacodynamics of a topical SYK inhibitor in cutaneous lupus erythematosus: A double-blind Phase Ib study.
Exp Dermatol
; 30(11): 1686-1692, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33336508
2.
Effects of a topical treatment with spleen tyrosine kinase inhibitor in healthy subjects and patients with cold urticaria or chronic spontaneous urticaria: Results of a phase 1a/b randomised double-blind placebo-controlled study.
Br J Clin Pharmacol
; 87(12): 4797-4808, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34020509
3.
Effect of belimumab on proteinuria and anti-phospholipase A2 receptor autoantibody in primary membranous nephropathy.
Nephrol Dial Transplant
; 35(4): 599-606, 2020 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31243451
4.
Anti-IL-7 receptor α monoclonal antibody (GSK2618960) in healthy subjects - a randomized, double-blind, placebo-controlled study.
Br J Clin Pharmacol
; 85(2): 304-315, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30161291
5.
Development of a whole body physiologically based model to characterise the pharmacokinetics of benzodiazepines. 1: Estimation of rat tissue-plasma partition ratios.
J Pharmacokinet Pharmacodyn
; 31(4): 269-98, 2004 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-15563004